Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade

Stock Track

01-09

Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.

The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.

However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1160380170"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160380170\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1160380170?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-09 13:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160380170","market":"hk","top_or_hot":-1,"title":"Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade","media":"Stock Track","content":"<p>Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.</p>\n\n<p>The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.</p>\n\n<p>However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-09 13:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.</p>\n\n<p>The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.</p>\n\n<p>However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀-B","start_time":0,"source_url":"","article_id":"1160380170","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160380170","pubTimestamp":1736399074,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Everest Medicines , a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀-B"},"translate_title":"股票赛道珠峰医药因控股股东大宗交易暴跌5.04%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.\nThe significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.\nHowever, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}